Pfizer, Moderna Inc, Britain discussed on TIME's Top Stories

TIME's Top Stories
|

Automatic TRANSCRIPT

Pfizer and bio. Intech say. They've won permission wednesday for emergency use of their covid nineteen vaccine in britain. The world's first corona virus shot that's backed by rigorous science and a major step toward eventually ending the pandemic. the move makes britain one of the first countries to begin vaccinating. Its population as it tries to curb. Europe's deadliest covid nineteen outbreak. Other countries aren't far behind the us. And the european union also are vetting. The pfizer shot along with a similar vaccine made by competitor. Moderna inc pfizer said it would immediately begin shipping limited supplies to the uk and has been gearing up for even wider distribution if given a similar nod by the us food and drug administration. A decision expected as early as next week but doses everywhere are scarce and initial. Supplies will be rationed until more is manufactured in the first several months of next year visor. Co albert birla called the uk decision. A moment we are focusing on moving with the same level of urgency to safely supply. A high quality vaccine around the world bore said in a statement while the uk has altered enough pfizer vaccine for twenty million people. It's not clear. How many will arrive. By year's end. And adding to the distribution challenges is that it must be stored at ultra cold temperatures two doses. Three weeks apart are required for protection first in line. The uk government says our frontline healthcare workers and nursing home residents followed by older adults british regulators. Also were considering. Another shot made by astrazeneca and oxford university but prime minister. Boris johnson has warned. We must i navigate a hard winter of restrictions to try to curb the virus until there's enough vaccine to go around. Every country has different rules determining when an experimental vaccine is safe and effective enough to use intense political pressure to be the first to roll out a rigorously. Scientifically tested shot colored the race in the us and britain even as researchers pledged to cut no corners and contrast china and russia have offered different vaccinations to their citizens ahead of late. Stage testing the shots made by us based pfizer and its german partner bio intech were tested in tens of thousands of people and while that study isn't complete early results suggest. The vaccine is ninety five percent effective at preventing mild to severe covid nineteen disease the company's told regulators that of the first one hundred seventy infections detected in study volunteers. Only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. This is an extraordinarily strong protection. Dr uber sahin. A bio intex. Ceo recently told the associated press. The companies are reported. No serious side effects. Although vaccine recipients may experience temporary pain and flu-like reactions immediately after injections but experts caution that a vaccine cleared for emergency use is still experimental and the final testing must be completed still to be determined is whether the pfizer bio tech shots protect against people spreading the coronavirus without showing symptoms. Another question is how long protection lasts. The vaccine also has been tested in only a small number of children none younger than twelve. And there's no information on its effects in pregnant women.

Coming up next